Search Results

She completed her undergraduate education at Providence College, receiving a B.S. in Biology and a B.A Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined degradation as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional PhD Program Chemical Biology

that MRAP2 regulates the signaling of multiple G protein-coupled receptors (GPCRs) through different structural While writing my thesis, I published another paper in the Journal of Biological Chemistry which described C-terminal tail is not a docking space for the arrestins, but rather a necessary modification leading to a structural

Southwestern Medical Center with Bruce Horazdovsky, Ph.D. the faculty in the Department of Pharmacology and Physiology at the University of Rochester Medical Center

Eldridge Distinguished Professor and Chair of the Department of Cell Biology & Physiology at The University Caron received a BS in Biology and BA in Philosophy at Emory University and a PhD at Duke University special emphasis on G protein coupled receptors and receptor activity modifying proteins in vascular biology

a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR) biology linked to various neuropsychiatric phenotypes, and my work will provide a basis for understanding aGPCR biology

Nanoengineering Department, Ken Vecchio helping set the foundation for the Nanoengineering Materials Research Center

He received his Ph.D. from the Centre for Cellular and Molecular Biology at Hyderabad, India, where he aims to work at the interface of GPCR molecular pharmacology, subcellular trafficking, and membrane biology

Ilana uses chemical biology-based methods to study the regulation and protein-protein interactions of Ilana graduated Summa cum laude from Cornell University, where she studied Chemistry and Chemical Biology

at Vanderbilt University before continuing her training as a postdoctoral fellow at the Vanderbilt Center

allosteric modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology

Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors

While in San Francisco, I completed Startup101 - a course a offered by the entrepreneurship center.

with the idea of a monthly newsletter in which we've curated the major advances in understanding GPCR biology

Her work involves the pharmacological and structural characterisation of novel putative antipsychotic

Gloriam About this episode David Gloriam is a Professor in Computational Receptor Biology at the University Gloriam on the web LinkedIn ResearchGate Twitter Google Scholar Computation Receptor Biology- Gloriam

Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department of Cell Biology Before joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000

She completed her undergraduate education at Providence College, receiving a B.S. in Biology and a B.A Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined as a therapeutic strategy. " Victoria Rasmussen on the web Tri-Institutional PhD Program in Chemical Biology

and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center interest in science originated from a young age and his desire to gain more knowledge about cancer biology They also shared their personal experiences and interest in the field of biology.

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn

GPCRs in Immunology and Oncology November 17, 2023 GPCRs as Therapeutic Modalities September 22, 2023 Structural

Discovering these receptors would be a significant breakthrough in cardiovascular biology as they could My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs.

Discovering new aspects of PAR signaling is important for increasing the fundamental knowledge of GPCR biology protease-activated receptors, particularly PAR1, and over the years she has discovered novel aspects of GPCR biology

During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge

Pharma in Denmark; Full professor, department chair and director of the institute for pharmaceutical Biology

There, I investigated Two-Pore-Potassium channels using electrophysiology, molecular and chemical biology from discovery to preclinical candidate nomination and to provide the tools to advance adhesion GPCR biology My expertise lies in exploring the biological properties and signaling pathways activated by aGPCRs,

She developed expertise over the past two decades studying structure/function relationships of GPCRs

trajectory, discoveries, and how their research contributed to the shared pool of knowledge about GPCR biology to connect, exchange, and collaborate to improve human health through a better understanding of GPCR biology

Tom initially focused on structure-activity relationships underlying spectral tuning and identified a micro-domains” and the “helix movement model of receptor activation” were confirmed later when crystal structures